Early Postoperative Inflammatory Markers Predict Major Complications After Rectal Cancer Surgery

Why It Matters

Early detection of complications enables timely interventions, potentially reducing morbidity and healthcare costs in colorectal surgery.

Key Takeaways

• CRP at 48 h predicts major postoperative complications
• NLR shows no significant predictive value at 48 h
• Open surgery yields higher 48 h CRP than laparoscopic
• ROC analysis confirms good discriminative ability of CRP
• Implementing CRP monitoring could improve postoperative care

Pulse Analysis

The postoperative inflammatory cascade has long been recognized as a harbinger of adverse outcomes in colorectal surgery. Among the myriad biomarkers, C‑reactive protein (CRP) and the neutrophil‑to‑lymphocyte ratio (NLR) are readily available, inexpensive, and routinely measured in most surgical wards. While prior retrospective analyses hinted at a correlation between early CRP spikes and complications, robust prospective data specific to rectal cancer resections have been scarce, leaving clinicians without clear thresholds for intervention.

The current prospective cohort of 98 rectal cancer patients, operated between October 2022 and January 2026, provides that missing evidence. Measurements taken at 24 and 48 hours post‑operation revealed that only CRP levels at the 48‑hour mark differed significantly between patients who experienced major complications and those who did not. Receiver‑operating‑characteristic (ROC) analysis yielded an area under the curve indicating strong discriminative power, and multivariate logistic regression confirmed CRP as an independent predictor. Conversely, NLR failed to demonstrate predictive utility, and open surgery was associated with higher CRP values than laparoscopic approaches.

These findings have immediate practical implications. Incorporating a 48‑hour CRP threshold into postoperative pathways could trigger earlier imaging, intensified monitoring, or prophylactic measures, potentially curbing morbidity and shortening hospital stays. Moreover, the data reinforce the clinical advantage of minimally invasive techniques, which appear to temper the inflammatory response. Future research should refine optimal CRP cut‑offs, explore integration with other risk scores, and assess cost‑effectiveness across diverse health systems. For surgeons and hospital administrators, the message is clear: systematic CRP surveillance is a low‑cost tool with high‑impact potential.